
3 Types of Startups that Healthcare Leaders Want to See More Of
During HLTH, I spoke with some investors and digital health executives about the types of startups that they haven’t encountered yet — but would like to.
During HLTH, I spoke with some investors and digital health executives about the types of startups that they haven’t encountered yet — but would like to.
Less than a year after its launch, microbiome profiling startup Jona has already given its user interface a makeover as a result of the user feedback it received. If you’re running a successful consumer- or patient-facing startup, acting on user feedback in a timely manner is “absolutely essential,” said Jona CEO Leo Grady.
Join us on February 26 at 3 pm ET, and we’ll dive into the key areas where practices are losing time and money and provide solutions to overcome them.
The digital health fundraising market seems to be truly normalizing following the highs and lows of the pandemic, according to market research. During the first half of this year, U.S. digital health startups raked in $5.7 billion across 266 deals.
How health tech startups can successfully adapt the principles to their business ideas
Here is a list of some of the most notable funding round announcements that took place this March in the provider technology space.
During a recent panel, Flare Capital Partners' Michael Greeley and Mount Sinai's Robbie Freeman shared some attributes that they think stand out among digital health startups that have found success in today's environment.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
At ViVE, investors and health system executives shared their biggest pet peeves when it comes to pitches from digital health startups.
In the venture capital community, there’s a bit of a debate about what matters more to digital health investors in today's fundraising environment — growth or profitability. Cathy Gao, a partner at Sapphire Ventures, thinks VCs are still putting a premium on growth, but she noted that the conversation is very nuanced.
This year, industry experts think that some digital health startups will have to confront their challenges more head-on than they did in 2023. Some companies may need to do things like fundraise at a lower valuation, explore opportunities for an acquisition or exit or, in some cases, consider the possibility of shutting down operations.
The financial outlook for the digital health sector is less than ideal, characterized by lower funding amounts, shrinking valuations, dwindling profitability and the collapse of Silicon Valley Bank. During a recent conference panel, four healthcare VCs discussed their reactions to this. They explained why the market has switched its focus from growth to value, as well gave advice to startups about what they need to know in this changing environment.
The Journey recently launched as a Phoenix-based venture studio designed to create new healthcare startups with diverse founders. The studio works with entrepreneurs from underrepresented backgrounds across the country, helping them prototype, scale and commercialize digital health platforms.
Going into 2023, investors think the abilities to demonstrate ROI and clinical validation will be the most important factors determining digital health companies' success, according to a new report. While the ROI factor is a given, clinical validation “is the best signal of patient value and historically has been under-captured in digital health," said Sunny Kumar, a partner at GSR Ventures.
Jonathan Bush has three rules he thinks digital health startups should follow as the country prepares for a likely recession. They should ensure their technology accomplishes a task that healthcare stakeholders need fulfilled, be very clear about how they can make more money doing their job than their competitors, and find "people who are unhinged enough" to try their product.
General Catalyst recently launched a $670 million healthcare investment fund. The fund, called Health Assurance Fund II, seeks to carry on the mission of the venture capital firm’s first healthcare-focused fund, but with a new focus on health system partnerships.
This is the fourth fund launched by Accelmed, a group of funds based in Israel and New York, which currently manages more than $300 million.